Biomarkers in Medicines Development—From Discovery to Regulatory Qualification and Beyond

Biomarkers are important tools in medicines development and clinical practice. Besides their use in clinical trials, such as for enrichment of patients, monitoring safety or response to treatment, biomarkers are a cornerstone of precision medicine. The European Medicines Agency (EMA) emphasised the...

Descripción completa

Detalles Bibliográficos
Autores principales: Hendrikse, Natalie M., Llinares Garcia, Jordi, Vetter, Thorsten, Humphreys, Anthony J., Ehmann, Falk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086587/
https://www.ncbi.nlm.nih.gov/pubmed/35559349
http://dx.doi.org/10.3389/fmed.2022.878942

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086587/
https://www.ncbi.nlm.nih.gov/pubmed/35559349
http://dx.doi.org/10.3389/fmed.2022.878942

Ejemplares similares